Form EFFECT Kezar Life Sciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 14, 2026 |
| Accession Number: | 0001140361-26-020547 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AULUMU Launches Ultra-Slim Aramid Fiber Case for Fold 8/Fold 8 Ultra
- VINFAST PARTNERS WITH AKF-BANK TO ACCELERATE DEALER NETWORK EXPANSION IN GERMANY
- TotalEnergies SE: Disclosure of Transactions in Own Shares
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
